Jan-Åke Gustafsson, University of Houston (IMAGE)

University of Houston

Jan-Åke Gustafsson, University of Houston

Caption

A team led by Dr. Jan-Åke Gustafsson at the University of Houston has demonstrated that the nuclear receptor liver X receptor beta shows promise as a potential therapeutic target for Parkinson's disease, as well as other neurological disorders.

Credit

Thomas Campbell

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.